Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kratom Use and Toxicities in the United States
William Eggleston, Robert Stoppacher, Kyle Suen, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2019) Vol. 39, Iss. 7, pp. 775-777
Closed Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review
Steven Eastlack, Elyse M. Cornett, Alan D. Kaye
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 55-69
Open Access | Times Cited: 138
Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected Indole-Based Kratom Alkaloids
Samuel Obeng, Shyam H. Kamble, Morgan E. Reeves, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 1, pp. 433-439
Open Access | Times Cited: 119
Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users
Darshan Singh, Nelson Jeng‐Yeou Chear, Suresh Narayanan, et al.
Journal of Ethnopharmacology (2019) Vol. 249, pp. 112462-112462
Closed Access | Times Cited: 79
Past-Year Kratom Use in the U.S.: Estimates From a Nationally Representative Sample
Joseph J. Palamar
American Journal of Preventive Medicine (2021) Vol. 61, Iss. 2, pp. 240-245
Open Access | Times Cited: 62
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Exploring the self-reported motivations of kratom (Mitragyna speciosa Korth.) use: a cross-sectional investigation
Oliver Grundmann, Charles A. Veltri, Diana Morcos, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 4, pp. 433-444
Closed Access | Times Cited: 31
In vitro and in vivo pharmacology of kratom
Takato Hiranita, Samuel Obeng, Abhisheak Sharma, et al.
Advances in pharmacology (2022), pp. 35-76
Closed Access | Times Cited: 23
Biomedical analysis of New Psychoactive Substances (NPS) of natural origin
Alfredo Fabrizio Lo Faro, Annagiulia Di Trana, Nunzia La Maida, et al.
Journal of Pharmaceutical and Biomedical Analysis (2019) Vol. 179, pp. 112945-112945
Closed Access | Times Cited: 41
Pharmacologic and clinical assessment of kratom: An update
C Michael White
American Journal of Health-System Pharmacy (2019) Vol. 76, Iss. 23, pp. 1915-1925
Closed Access | Times Cited: 40
Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder
Anna M. Gutridge, Soumen Chakraborty, Balázs Varga, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28
Forensic Implications of Kratom: Kratom Toxicity, Correlation with Mitragynine Concentrations, and Polypharmacy
Donna M Papsun, William Schroeder, Justin O. Brower, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 272-281
Closed Access | Times Cited: 12
Translating Kratom-Drug Interactions: From Bedside to Bench and Back
Rakshit S. Tanna, Nadja B. Cech, Nicholas H. Oberlies, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 8, pp. 923-935
Open Access | Times Cited: 12
A case report of reversible ischemic MRI changes and discussion of possible link to kratom use
Danah Bakir, Christian J. Konopka, Sindhu Reddy Pisati, et al.
Neuroimage Reports (2025) Vol. 5, Iss. 2, pp. 100261-100261
Closed Access
Predicted Mode of Binding to and Allosteric Modulation of the μ-Opioid Receptor by Kratom’s Alkaloids with Reported Antinociception In Vivo
Yuchen Zhou, Steven Ramsey, Davide Provasi, et al.
Biochemistry (2020) Vol. 60, Iss. 18, pp. 1420-1429
Open Access | Times Cited: 28
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26
Herbal and dietary supplement induced liver injury: Highlights from the recent literature
Stephanie Woo, William D. Davis, Soorya Aggarwal, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 9, pp. 1019-1041
Open Access | Times Cited: 25
A Cautionary Tale of Herbal Supplements: What We Have Learned from Kratom
Stephanie T. Weiss, Jeffrey Brent
Current Addiction Reports (2023) Vol. 10, Iss. 1, pp. 1-8
Closed Access | Times Cited: 10
Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse Effects
Pietro Brunetti, Alfredo Fabrizio Lo Faro, Anastasio Tini, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 10, pp. 309-309
Open Access | Times Cited: 27
Kratom: A systematic review of toxicological issues
Sarah Kerrigan, Stephanie Basiliere
Wiley Interdisciplinary Reviews Forensic Science (2021) Vol. 4, Iss. 1
Closed Access | Times Cited: 23
Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature
Cornel N. Stanciu, Saeed Ahmed, Samantha A. Gnanasegaram, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 5, pp. 509-528
Closed Access | Times Cited: 14
Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa)
Chad Hartley, Marilyn N. Bulloch, Scott Penzak
The Journal of Clinical Pharmacology (2021) Vol. 62, Iss. 5, pp. 577-593
Closed Access | Times Cited: 19
Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant
Alessandro Vento, Simone De Persis, Sergio De Filippis, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 18
Utility of Therapeutic Drug Monitoring in Identifying Clinically Significant Interactions Between St. John's Wort and Prescription Drugs
Vanessa Steenkamp, H Parkar, Amitava Dasgupta
Therapeutic Drug Monitoring (2023) Vol. 45, Iss. 1, pp. 35-44
Open Access | Times Cited: 7
Red kratom and red corvette: A case of mania induced by kratom withdrawal
Mohammmad Abidali, Guitelle St.Victor, Shady Mashaly, et al.
The International Journal of Psychiatry in Medicine (2024)
Closed Access | Times Cited: 2
Herb-drug Interactions in Neuropsychiatric Pharmacotherapy – A Review of Clinically Relevant Findings
Tram T. Le, Sarah R. McGrath, Pius S. Fasinu
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1736-1751
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top